MD. MSc. Cardiologist. Assoc Professor . Clinical Research. FACC. FSIAC Tropical Cardiology . Scientific Journalist
Venezuela
Joined March 2010
- Tweets37.9K
- Following2.3K
- Followers3.9K
- Likes4.6K
Igor Morr retweeted
❤️ Comienza una nueva edición de #CorazónDeMamá.
La Dra. Ana Múnera nos invita a sumarnos a esta campaña de @SIAC_cardio, @MujerSIAC , @GoRedForWomen y @IAHFnews para concientizar sobre la salud cardiovascular durante el embarazo.
Este año hablaremos sobre la preeclampsia: prevención, síntomas y detección temprana. Porque informar también salva vida.
🔗siacardio.com/corazondemama2…
#SaludMaterna #Preeclampsia
Igor Morr retweeted
A 🆕 ACC Scientific Statement outlines the rapidly evolving landscape of gene-editing therapies & their growing relevance to #CVD, offering clinicians an overview of both the promise and the challenges of this transformative technology.
Read more: bit.ly/4sPj9Wv #JACC
Igor Morr retweeted
Burden of chronic kidney disease and outcomes following hospitalisation for heart failure
bit.ly/47jqg0I
Igor Morr retweeted
facebook.com/share/r/16cfoi1…
📈 ECG Cheat Sheet 🎯
Drop a ❤️ if you find this helpful! Feel free to share!
#ECG #EKG #Cardiology #MedStudent #NursingSchool
Igor Morr retweeted
🫀 𝗖𝗹𝗼𝗽𝗶𝗱𝗼𝗴𝗿𝗲𝗹 𝘃𝘀 𝗔𝘀𝗽𝗶𝗿𝗶𝗻𝗮 𝗽𝗼𝘀𝘁-𝗣𝗖𝗜: 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗶𝗮 𝗮 𝟭𝟬 𝗮𝗻̃𝗼𝘀 (𝗛𝗢𝗦𝗧-𝗘𝗫𝗔𝗠)
⬇️⬇️⬇️⬇️
🧠 𝘿𝙞𝙨𝙚𝙣̃𝙤 𝙙𝙚𝙡 𝙚𝙨𝙩𝙪𝙙𝙞𝙤
👥 𝙋𝙤𝙗𝙡𝙖𝙘𝙞𝙤́𝙣: Pacientes estables tras 6–18 meses de DAPT luego de angioplastia (PCI)
💊 𝙄𝙣𝙩𝙚𝙧𝙫𝙚𝙣𝙘𝙞𝙤́𝙣: Clopidogrel 75 mg/día
⚖️ 𝘾𝙤𝙢𝙥𝙖𝙧𝙖𝙙𝙤𝙧: Aspirina 100 mg/día
🎯 𝙊𝙪𝙩𝙘𝙤𝙢𝙚 𝙥𝙧𝙞𝙢𝙖𝙧𝙞𝙤:
•Muerte CV
•IAM no fatal
•ACV
•Rehospitalización por SCA
•Sangrado mayor
📊 𝙍𝙚𝙨𝙪𝙡𝙩𝙖𝙙𝙤𝙨 𝙥𝙧𝙞𝙣𝙘𝙞𝙥𝙖𝙡𝙚𝙨 (𝙨𝙚𝙜𝙪𝙞𝙢𝙞𝙚𝙣𝙩𝙤 10 𝙖𝙣̃𝙤𝙨)
🔥 𝙀𝙣𝙙𝙥𝙤𝙞𝙣𝙩 𝙘𝙤𝙢𝙥𝙪𝙚𝙨𝙩𝙤
•Clopidogrel: 𝟮𝟱.𝟰%
•Aspirina: 𝟮𝟴.𝟱%
➡️ 𝙍𝙚𝙙𝙪𝙘𝙘𝙞𝙤́𝙣 𝙖𝙗𝙨𝙤𝙡𝙪𝙩𝙖 ~𝟯.𝟭%
🧠 𝙀𝙫𝙚𝙣𝙩𝙤𝙨 𝙞𝙣𝙙𝙞𝙫𝙞𝙙𝙪𝙖𝙡𝙚𝙨
𝙀𝙫𝙚𝙣𝙩𝙤 𝘾𝙡𝙤𝙥𝙞𝙙𝙤𝙜𝙧𝙚𝙡 𝘼𝙨𝙥𝙞𝙧𝙞𝙣𝙖
🧠 ACV 4.6% 6.4%
🩸 Sangrado mayor 5.6% 7.7%
🫀 Reingreso por SCA 8.7% 11%
👉 Beneficio consistente en:
•𝙀𝙫𝙚𝙣𝙩𝙤𝙨 𝙞𝙨𝙦𝙪𝙚́𝙢𝙞𝙘𝙤𝙨
•𝙎𝙖𝙣𝙜𝙧𝙖𝙙𝙤 (𝙙𝙖𝙩𝙤 𝙘𝙡𝙖𝙫𝙚)
⚖️ 𝙄𝙣𝙩𝙚𝙧𝙥𝙧𝙚𝙩𝙖𝙘𝙞𝙤́𝙣 𝙛𝙞𝙨𝙞𝙤𝙥𝙖𝙩𝙤𝙡𝙤́𝙜𝙞𝙘𝙖
🔬 𝘾𝙡𝙤𝙥𝙞𝙙𝙤𝙜𝙧𝙚𝙡 𝙫𝙨 𝙖𝙨𝙥𝙞𝙧𝙞𝙣𝙖:
🧬 𝘾𝙡𝙤𝙥𝙞𝙙𝙤𝙜𝙧𝙚𝙡 (𝙋𝟮𝙔𝟭𝟮)
•Inhibición más específica de activación plaquetaria
•Menor daño mucoso GI
•Menor inflamación vascular
🧪 𝘼𝙨𝙥𝙞𝙧𝙞𝙣𝙖
•Inhibición COX-1
•Mayor riesgo de sangrado GI
•Efecto menos selectivo
🚨 𝙃𝙖𝙡𝙡𝙖𝙯𝙜𝙤 𝙘𝙡𝙞́𝙣𝙞𝙘𝙤 𝙙𝙞𝙨𝙧𝙪𝙥𝙩𝙞𝙫𝙤
👉 Tradicionalmente:
➡️ Aspirina = estándar de monoterapia post-DAPT
👉 Este estudio demuestra:
➡️ 𝘾𝙡𝙤𝙥𝙞𝙙𝙤𝙜𝙧𝙚𝙡 𝙚𝙨 𝙨𝙪𝙥𝙚𝙧𝙞𝙤𝙧 𝙖 𝙡𝙖𝙧𝙜𝙤 𝙥𝙡𝙖𝙯𝙤 (𝟭𝟬 𝙖𝙣̃𝙤𝙨)
📉 𝙈𝙖𝙜𝙣𝙞𝙩𝙪𝙙 𝙙𝙚𝙡 𝙗𝙚𝙣𝙚𝙛𝙞𝙘𝙞𝙤
🔻 Reducción absoluta modesta pero clínicamente relevante
📈 Beneficio sostenido en el tiempo
⚠️ Mejor perfil 𝙞𝙨𝙦𝙪𝙚́𝙢𝙞𝙘𝙤 + 𝙝𝙚𝙢𝙤𝙧𝙧𝙖́𝙜𝙞𝙘𝙤 𝙨𝙞𝙢𝙪𝙡𝙩𝙖́𝙣𝙚𝙖𝙢𝙚𝙣𝙩𝙚
🧠 𝘼𝙥𝙡𝙞𝙘𝙖𝙘𝙞𝙤́𝙣 𝙥𝙧𝙖́𝙘𝙩𝙞𝙘𝙖
📌 𝘾𝙤𝙣𝙨𝙞𝙙𝙚𝙧𝙖𝙧 𝙘𝙡𝙤𝙥𝙞𝙙𝙤𝙜𝙧𝙚𝙡 𝙘𝙤𝙢𝙤 𝙥𝙧𝙞𝙢𝙚𝙧𝙖 𝙤𝙥𝙘𝙞𝙤́𝙣 𝙚𝙣:
•Post-PCI estable tras DAPT
•Alto riesgo de sangrado GI
•Historia de eventos isquémicos recurrentes
•Intolerancia a aspirina
⚠️ 𝙇𝙞𝙢𝙞𝙩𝙖𝙘𝙞𝙤𝙣𝙚𝙨 𝙧𝙚𝙡𝙚𝙫𝙖𝙣𝙩𝙚𝙨
🌏 Mayoría población asiática → posible variabilidad farmacogenómica (CYP2C19)
🧬 Metabolismo de clopidogrel dependiente de activación hepática
❗ No aplica automáticamente a todos los fenotipos globales
‼️Si te sirve: ❤️ Me gusta | 🔁 Repost | ➕ Follow para más #MedED en #ClubCrit 😄🧠🫶
👇🏼👇🏼👇🏼👇🏼
📚📖#ClubCrit
#AAS #ASA #Clopidogrel #Aspirina #CardioX #CritCare #UCI #ICU #CriticalCare #Diagnóstico #icu #intensivecare #diagnosis #management #POCUS #VExUS #MedicinaBasadaEnEvidencia #Terapia #MedEd #Medicina #FOAMed #FOAMcc #CuidadoCrítico #MedX #EducaciónMédica #MedIntensiva #MedXCommunity #MedicinaCrítica #MedED #CritCare #ICUManagement #MustRead #LecturaRecomendada
Igor Morr retweeted
Among working-age adults in the US, COVID was associated with higher risks for acute kidney injury (AKI), chronic kidney disease (CKD), or end-stage renal disease (ESRD) than influenza. The risk for AKI was greatest soon after infection, whereas the elevated risk for CKD persisted over a longer follow-up period. mdsc.pe/3NIzr4q
Igor Morr retweeted
This post hoc analysis of ISCHEMIA with 4-year outcome demonstrated that ischemia severity by #CMR had a stronger association with all ISCHEMIA trial endpoints compared with SPECT/echo. jacc.org/doi/10.1016/j.jcmg.… #JACCIMG
Igor Morr retweeted
This brief report from @MountSinaiHeart examines outcomes of rotational atherectomy in 3,963 patients over 65 yrs. Read the #JACCINT paper for insights from a high-volume center on what age means for safety & success jacc.org/doi/10.1016/j.jcin.…
#cvGeri @Drroxmehran @JasonGKaplanMD
Igor Morr retweeted
sesión webinar de acceso libre :¿Donde estamos en la imagen en el interencionismo estructural? no te la pierdas.Una nueva accionarial de formación libre de la SEIC @imagencardica
📣 No olvides registrarte gratuitamente en la próxima sesión 📣
Avances en Imagen en Intervencionismo Estructural 2026
👨💻 buff.ly/Kei25eD ◀️
Con Cruz, Li y Barreiro y la moderación de García Fernández
Sesión Zoom gratis con registro previo
Avances en Imagen Cardíaca 2026
📅 18 feb - 19h (Madrid, CET)
ALT 📣 No olvides registrarte gratuitamente en la próxima sesión 📣 Avances en Imagen en Intervencionismo Estructural 2026
Igor Morr retweeted
Próximo inicio del curso #CampusSEC "Decisiones complejas en el paciente isquémico"
🔴 Una revisión práctica del diagnóstico y manejo de la cardiopatía isquémica en casos complejos: valoración funcional, caracterización de placa, reestenosis y riesgo trombótico.
🔗 Info: campus.secardiologia.es/es/c…
@drjmora @Monicaferqu @preventiva_SEC @shci_sec @ResiSec @JovenesSec
Igor Morr retweeted
➡️ ICD decisions should not rely on EF alone.
Insight from the DERIVATE NICM study
1,384 NICM patients (with chronic heart failure and LVEF < 50%) from 21 centres in the US and Europe
✅ The DERIVATE 2.0 score performs better than the current criteria
A multimodal score combining:
Sex
LVEF
LGE presence
LGE location
showed substantially improved prediction of major arrhythmic events compared to traditional EF-based models. #whyCMR
#EHJCVI 🫀ICD selection in NICM isn’t just about LVEF <35% or LGE %, location matters 📌 Midwall LGE identifies patients with higher MAACE risk ⚡DERIVATE Risk Score 2.0 (LGE location + LVEF + sex) delivers a +54% NRI vs LVEF alone. Read more 👉 doi.org/10.1093/ehjci/jeaf19…
Igor Morr retweeted
Podcast - Predicting cardiovascular events from routine mammograms using machine learning
In this episode of the Heart podcast, Digital Media Editor Professor James Rudd is joined by Dr Jennifer Barraclough from Sydney, Australia. They discuss her paper, which describes how a deep learning model can predict the risk of future cardiovascular events using mammogram images, along with age, and how this approach compares with existing methods, as well as the opportunities it might bring for improving the burden of cardiovascular disease among women. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us reach more people - thank you!
Podcast: bit.ly/49czDRQ
Paper: bit.ly/3LAFXZq
Igor Morr retweeted
Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications
bit.ly/3I28FRq
Igor Morr retweeted
Simplifying nutrition info can help consumers make healthier choices and lower #CVD risk, per new ACC guidance in #JACC. The guidance backs a standardized front-of-pack label highlighting key nutrients to limit or encourage.
Get the details: bit.ly/4pMXfkK
Igor Morr retweeted
Cardiac rehabilitation: the gateway for secondary prevention - heart.bmj.com/content/110/24…
Igor Morr retweeted
Advancing clinical management of left ventricular thrombosis: prevention, detection and treatment modalities in the modern era
bit.ly/40oGmCR
Igor Morr retweeted
Sex hormone patterns—low testosterone in men and high 17β-estradiol in women—are linked to TdP risk and outcomes. These effects on cardiac electrophysiology support exploring sex-specific hormone-modulating therapies. jacc.org/doi/10.1016/j.jacep… #JACCCEP #EPeeps
Igor Morr retweeted
#DAPT after valve-in-valve #TAVR may be associated with a lower 1-yr incidence of stroke. In contrast, no significant difference was observed for other major ischemic and bleeding outcomes or for premature valve deterioration. jacc.org/doi/10.1016/j.jcin.… #JACCINT @saia_francesco
